Physician

Johnny Gurgen, D.O.

According to 2025 Medicare claims, Johnny Gurgen, D.O. (NPI: 1962666966) practices dermatology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is JOHNNY GURGEN DO PA (NPI: 1770856833; TIN: 453825600) and primary practice location at 34748-3924.

Gurgen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,063 traditional Medicare patients, billed 43,715 HCPCS/CPT codes, and received $3,563,170 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 662 prescription claims across 479 beneficiaries totaling $12,783 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). Open Payments data shows 6 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $770,789 to $3,563,170. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $21,741 to $12,783. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $770,789 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $703,546 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $979,679 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,083,535 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,341,276 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $899,273 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $850,112 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,167,003 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,680,147 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,563,170 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156303,106$770,789
20166392,828$703,546
20171,39212,129$979,679
20181,49116,826$1,083,535
20191,59016,757$1,341,276
20201,1676,954$899,273
20211,1305,880$850,112
20221,21610,207$1,167,003
20231,42918,875$1,680,147
20242,06343,715$3,563,170

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2015 Drug cost: $21,741 (USD; Tot_Drug_Cst)2016 Drug cost: $15,839 (USD; Tot_Drug_Cst)2017 Drug cost: $20,462 (USD; Tot_Drug_Cst)2018 Drug cost: $11,443 (USD; Tot_Drug_Cst)2019 Drug cost: $5,560 (USD; Tot_Drug_Cst)2020 Drug cost: $6,353 (USD; Tot_Drug_Cst)2021 Drug cost: $5,980 (USD; Tot_Drug_Cst)2022 Drug cost: $1,504 (USD; Tot_Drug_Cst)2023 Drug cost: $5,169 (USD; Tot_Drug_Cst)2024 Drug cost: $12,783 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015479798$21,741
2016523860$15,839
20175551,013$20,462
2018486694$11,443
2019275357$5,560
2020137192$6,353
202192130$5,980
20224045$1,504
2023186232$5,169
2024479662$12,783

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth1,1551,454$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,4982,604$68
17000Destruction of precancer skin growth, 1 growth1,0501,342$36
88305Pathology examination of tissue using a microscope, intermediate complexity1,5395,622$25
17003Destruction of precancer skin growth, 2-14 growths8214,755$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline HyclateDoxycycline Hyclate2522,339$2,226
MupirocinMupirocin2183,362$1,367
Gentamicin SulfateGentamicin Sulfate35664$1,200
CephalexinCephalexin61463$631
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav59539$619

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$126Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Johnny Gurgen, D.O.?

Tedicare shows public-source Medicare data for Johnny Gurgen, D.O. (NPI 1962666966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Johnny Gurgen, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Johnny Gurgen, D.O.?

Johnny Gurgen, D.O. is linked to JOHNNY GURGEN DO PA (billing NPI 1770856833) in the available physician profile data.

Does Johnny Gurgen, D.O. have Open Payments data?

Johnny Gurgen, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.